← Back to Search
Pretreatment Prognostic Value Of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Vascular, Texture, Shape, And Size Parameters Compared With Traditional Survival Indicators Obtained From Locally Advanced Breast Cancer Patients
M. Pickles, M. Lowry, P. Gibbs
Published 2016 · Medicine
Download PDFAnalyze on Scholarcy
ObjectivesThe aim of this study was to determine if associations exist between pretreatment dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI)–based metrics (vascular kinetics, texture, shape, size) and survival intervals. Furthermore, the aim of this study was to compare the prognostic value of DCE-MRI parameters against traditional pretreatment survival indicators. Materials and MethodsA retrospective study was undertaken. Approval had previously been granted for the retrospective use of such data, and the need for informed consent was waived. Prognostic value of pretreatment DCE-MRI parameters and clinical data was assessed via Cox proportional hazards models. The variables retained by the final overall survival Cox proportional hazards model were utilized to stratify risk of death within 5 years. ResultsOne hundred twelve subjects were entered into the analysis. Regarding disease-free survival–negative estrogen receptor status, T3 or higher clinical tumor stage, large (>9.8 cm3) MR tumor volume, higher 95th percentile (>79%) percentage enhancement, and reduced (>0.22) circularity represented the retained model variables. Similar results were noted for the overall survival with negative estrogen receptor status, T3 or higher clinical tumor stage, and large (>9.8 cm3) MR tumor volume, again all been retained by the model in addition to higher (>0.71) 25th percentile area under the enhancement curve.Accuracy of risk stratification based on either traditional (59%) or DCE-MRI (65%) survival indicators performed to a similar level. However, combined traditional and MR risk stratification resulted in the highest accuracy (86%). ConclusionsMultivariate survival analysis has revealed that model-retained DCE-MRI variables provide independent prognostic information complementing traditional survival indicators and as such could help to appropriately stratify treatment.
This paper references
Survival outcomes of breast cancer patients who receive neoadjuvant chemotherapy: association with dynamic contrast-enhanced MR imaging with computer-aided evaluation.
A. Yi (2013)
Assessing response in breast cancer with dynamic contrast-enhanced magnetic resonance imaging: Are signal intensity–time curves adequate?
D. Woolf (2014)
Texture analysis in assessment and prediction of chemotherapy response in breast cancer
A. Ahmed (2013)
Quantification of Heterogeneity as a Biomarker in Tumor Imaging: A Systematic Review
L. Alic (2014)
Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice?
Fergus Davnall (2012)
Can contrast-enhanced MR imaging predict survival in breast cancer?
B. Bóné (2003)
A Measure for Circularity of Digital Figures
R. Haralick (1974)
Quantifying Tumor Vascular Heterogeneity with Dynamic Contrast-Enhanced Magnetic Resonance Imaging: A Review
Xiangyu Yang (2011)
Measurement for circularity of digital figures
RM Haralick (1974)
MRI Enhancement in Stromal Tissue Surrounding Breast Tumors: Association with Recurrence Free Survival following Neoadjuvant Chemotherapy
E. Jones (2013)
Imaging Tumor Vascular Heterogeneity and Angiogenesis using Dynamic Contrast-Enhanced Magnetic Resonance Imaging
A. Jackson (2007)
The Changing World of Breast Cancer: A Radiologist's Perspective
C. Kuhl (2016)
Prognostic value of pretreatment dynamic contrast-enhanced MR imaging in breast cancer patients receiving neoadjuvant chemotherapy: Overall survival predicted from combined time course and volume analysis
M. G. Heldahl (2010)
Predicting survival and early clinical response to primary chemotherapy for patients with locally advanced breast cancer using DCE‐MRI
Roar Johansen (2009)
Segmentation of a high-resolution urban scene using texture operators
R. Conners (1984)
MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival.
S. Partridge (2005)
Use of dynamic contrast-enhanced MR imaging to predict survival in patients with primary breast cancer undergoing neoadjuvant chemotherapy.
S. Li (2011)
Geometric property measurement. In:Digital Picture Processing
A Rosenfeld (1982)
Preoperative chemotherapy for women with operable breast cancer.
J. Mieog (2007)
Meta-analysis of the association of breast cancer subtype and pathologic complete response to neoadjuvant chemotherapy.
Nehmat Houssami (2012)
Index for rating diagnostic tests. Cancer. 1950;3:32–35
WJ Youden (1950)
Prognostic value of pre-treatment DCE-MRI parameters in predicting disease free and overall survival for breast cancer patients undergoing neoadjuvant chemotherapy.
M. Pickles (2009)
Prognostic value DCE-MRI parameters in predicting factor disease free survival and overall survival for breast cancer patients.
N. Tuncbilek (2012)
MRI contrast agents: Basic chemistry and safety
D. Hao (2012)
Metastasis: Dissemination and growth of cancer cells in metastatic sites
A. Chambers (2002)
Geometric property measurement
Index for rating diagnostic tests
W. Youden (1950)
Correlation of the apparent diffusion coefficient value and dynamic magnetic resonance imaging findings with prognostic factors in invasive ductal carcinoma
S. K. Jeh (2011)
Textural Features for Image Classification
R. Haralick (1973)
Quantifying heterogeneity in human tumours using MRI and PET.
M. Asselin (2012)
Improving tumour heterogeneity MRI assessment with histograms
N. Just (2014)
Impact of Neoadjuvant Chemotherapy on Locoregional Surgical Treatment of Breast Cancer
M. F. Eleftherios P. Mamounas MD (2015)
Optimized breast MRI functional tumor volume as a biomarker of recurrence‐free survival following neoadjuvant chemotherapy
N. Jafri (2014)
Prognostic value of DCE-MRI in breast cancer patients undergoing neoadjuvant chemotherapy: a comparison with traditional survival indicators
M. Pickles (2014)
Association between survival in patients with primary invasive breast cancer and computer aided MRI
M. Dietzel (2013)
Assessing response in breast cancer with dynamic contrast-enhancedmagnetic resonance imaging: are signal intensity-time curves adequate? Breast Cancer
DK Woolf (2014)
Diffusion-weighted (DW) and dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) for monitoring anticancer therapy
A. Padhani (2010)
Current approaches for neoadjuvant chemotherapy in breast cancer.
R. Connolly (2013)
Breast cancer metastasis: markers and models
B. Weigelt (2005)
This paper is referenced by
CT-Based Radiomic Signature as a Prognostic Factor in Stage IV ALK-Positive Non-small-cell Lung Cancer Treated With TKI Crizotinib: A Proof-of-Concept Study
H. Li (2020)
MRI texture analysis in differentiating luminal A and luminal B breast cancer molecular subtypes - a feasibility study
Kirsi Holli-Helenius (2017)
Characterization of Sub‐1 cm Breast Lesions Using Radiomics Analysis
P. Gibbs (2019)
Predictive and prognostic value of CT based radiomics signature in locally advanced head and neck cancers patients treated with concurrent chemoradiotherapy or bioradiotherapy and its added value to Human Papillomavirus status.
Dan Ou (2017)
Defining the biological and clinical basis of radiomics: towards clinical imaging biomarkers
P. Grossmann (2018)
Heterogeneous Enhancement Patterns of Tumor-adjacent Parenchyma at MR Imaging Are Associated with Dysregulated Signaling Pathways and Poor Survival in Breast Cancer.
J. Wu (2017)
Perfusion Parameters on Breast Dynamic Contrast-Enhanced MRI Are Associated With Disease-Specific Survival in Patients With Triple-Negative Breast Cancer.
Vivian Youngjean Park (2017)
Evaluation of Early Response to Neoadjuvant Chemotherapy or Breast Cancer : Usefulness of Texture Analysis of DCE and Histogram Analysis of DW-MRI [Presidential Award Proceedings]
Yoshifumi Kuroki (2019)
Will traditional biopsy be substituted by radiomics and liquid biopsy for breast cancer diagnosis and characterisation?
F. Pesapane (2020)
Comparing Diagnostic Pathway of Two Patients Squamous Cell Carcinoma of the Breast-Favourable Diagnostic Input of CESM
Sana Pascaline (2016)
Predicting the response to neoadjuvant chemotherapy for breast cancer: wavelet transforming radiomics in MRI
J. Zhou (2020)
Role of texture analysis in breast MRI as a cancer biomarker: A review
Rhea D Chitalia (2019)
Exploring the complementarity of THz pulse imaging and DCE-MRIs: Toward a unified multi-channel classification and a deep learning framework
Xiao-Xia Yin (2016)
LGE-CMR-derived texture features reflect poor prognosis in hypertrophic cardiomyopathy patients with systolic dysfunction: preliminary results
Sainan Cheng (2018)
Automated volumetric radiomic analysis of breast cancer vascularization improves survival prediction in primary breast cancer
M. Dietzel (2020)
Radiomics in Breast Imaging from Techniques to Clinical Applications: A Review
S. H. Lee (2020)
Feasibility of contrast-enhanced MRI derived textural features to predict overall survival in locally advanced breast cancer
Ioanna Chronaiou (2019)
Texture Analysis and Machine Learning for Detecting Myocardial Infarction in Noncontrast Low-Dose Computed Tomography: Unveiling the Invisible
M. Mannil (2018)
Radiomics-Based Machine Learning Technology Enables Better Differentiation Between Glioblastoma and Anaplastic Oligodendroglioma
Yimeng Fan (2019)
Tumor texture parameters of invasive ductal breast carcinoma in neoadjuvant chemotherapy: early identification of non-responders on breast MRI.
M. Nadrljanski (2020)
Shear Wave Speed of the Lesion in Preoperative Breast Ultrasonography: Association with Disease-free Survival of Patients with Primary Operable Invasive Breast Cancer.
Youichi Machida (2018)
Radiomics Signature on Magnetic Resonance Imaging: Association with Disease-Free Survival in Patients with Invasive Breast Cancer
Hyunjin Park (2018)
Texture analysis of paraspinal musculature in MRI of the lumbar spine: analysis of the lumbar stenosis outcome study (LSOS) data
M. Mannil (2018)
Radiomic phenotype features predict pathological response in non-small cell lung cancer.
T. Coroller (2016)
Percentage change of primary tumor on 18F-FDG PET/CT as a prognostic factor for invasive ductal breast cancer with axillary lymph node metastasis
J. Yoo (2017)
Prediction of Chemoresistance in Women Undergoing Neo-Adjuvant Chemotherapy for Locally Advanced Breast Cancer: Volumetric Analysis of First-Order Textural Features Extracted from Multiparametric MRI
M. Panzeri (2018)
The Application of Radiomics in Breast MRI: A Review
Dong-Man Ye (2020)
Performance evaluation of texture analysis based on kinetic parametric maps from breast DCE‐MRI in classifying benign from malignant lesions
Zejun Jiang (2020)
Preclinical study of diagnostic performances of contrast-enhanced spectral mammography versus MRI for breast diseases in China
Q. Wang (2016)
Breast Cancer Heterogeneity: MR Imaging Texture Analysis and Survival Outcomes.
J. Kim (2017)
Textural features of dynamic contrast‐enhanced MRI derived model‐free and model‐based parameter maps in glioma grading
Tian Xie (2018)
Radiomics and imaging genomics in precision medicine
G. Lee (2017)See more